Additionally, TYMSOS was used in a prognostic model as one of thirteen lncRNAs related to M6A regulators, a certain type of mRNA modification, that is also of importance in cancer (64), as one of 18 immune-related lncRNAs for clinical prediction in head and neck squamous cell carcinoma due to its potential to modulate tumor microenvironment (65). The gene discussed is TYMSOS; the disease is neoplasm.